Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures
NCT ID: NCT00384358
Last Updated: 2013-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
108 participants
INTERVENTIONAL
2006-12-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of rhBMP-2/CPM in Closed Fractures of the Humerus
NCT00384852
A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures
NCT00387686
Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures
NCT00161629
Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)
NCT01908751
Using Alternative Implants for the Surgical Treatment of Hip Fractures (The FAITH Study)
NCT00761813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
1.0 mg/mL rhBMP-2/CPM + surgical fixation
rhBMP-2/CPM
one time injection of 3-5 mL test article at time of internal fracture fixation
B
2.0 mg/mL rhBMP-2/CPM + surgical fixation
rhBMP-2/CPM
one time injection of 3-5 mL test article at time of internal fracture fixation
C
Control: Surgical fixation
surgical intervention alone
surgical internal fixation of fracture defines the standard of care group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rhBMP-2/CPM
one time injection of 3-5 mL test article at time of internal fracture fixation
rhBMP-2/CPM
one time injection of 3-5 mL test article at time of internal fracture fixation
surgical intervention alone
surgical internal fixation of fracture defines the standard of care group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute fracture of the proximal femur: displaced femoral neck fracture or unstable intertrochanteric femur fracture.
* Anatomic reduction (open or closed) and internal fixation within 48 hours following injury using any one of the following fixation constructs: 1) multiple parallel interfragmentary screws; 2) sliding hip screw and side plate fixation; or 3) cephalomedullary nail.
Exclusion Criteria
* Previous arthroplasty of contralateral (unaffected) hip.
* Planned procedure(s) to stimulate fracture healing after internal fixation of the fractured hip.
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Aurora, Colorado, United States
Pfizer Investigational Site
New Haven, Connecticut, United States
Pfizer Investigational Site
Clearwater, Florida, United States
Pfizer Investigational Site
Pinellas Park, Florida, United States
Pfizer Investigational Site
Decatur, Georgia, United States
Pfizer Investigational Site
New Brunswick, New Jersey, United States
Pfizer Investigational Site
Brooklyn, New York, United States
Pfizer Investigational Site
Elmhurst, New York, United States
Pfizer Investigational Site
Liverpool, New South Wales, Australia
Pfizer Investigational Site
Herston, Queensland, Australia
Pfizer Investigational Site
Adelaide, South Australia, Australia
Pfizer Investigational Site
Melbourne, Victoria, Australia
Pfizer Investigational Site
Parkville, Victoria, Australia
Pfizer Investigational Site
Ajax, Ontario, Canada
Pfizer Investigational Site
Chatham, Ontario, Canada
Pfizer Investigational Site
Scarborough Village, Ontario, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Oulu, , Finland
Pfizer Investigational Site
Turku, , Finland
Pfizer Investigational Site
Créteil, , France
Pfizer Investigational Site
Marseille, , France
Pfizer Investigational Site
Berlin, , Germany
Pfizer Investigational Site
Münster, , Germany
Pfizer Investigational Site
Budapest, , Hungary
Pfizer Investigational Site
Debrecen, , Hungary
Pfizer Investigational Site
Bergen, , Norway
Pfizer Investigational Site
Oslo, , Norway
Pfizer Investigational Site
Link?ping, , Sweden
Pfizer Investigational Site
Edinburgh, , United Kingdom
Pfizer Investigational Site
Norwich, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B1921004
Identifier Type: -
Identifier Source: secondary_id
3100N7-211
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.